{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-061483","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.861115+00:00","generated_at":"2026-06-08T07:33:53.598952+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aveanna Q3 revenue up 7.9% to $478M; net loss $102.4M on $105.1M impairment; raises FY guidance","bullets":["Revenue $478.0M (+7.9% YoY); gross margin $147.3M (+9.4%).","Net loss $102.4M includes $105.1M non-cash goodwill impairment vs net income $24.3M in Q3 2022.","Adjusted EBITDA $36.2M (+46.2% YoY); adjusted net loss per share $(0.03) unchanged.","FY 2023 revenue guidance raised to $1.87B-$1.88B; Adj. EBITDA guidance raised to $134M-$137M.","CEO cites continued momentum and execution on 2023 initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-061483","json":"https://secwatch.observer/filing/0000950170-23-061483.json","markdown":"https://secwatch.observer/filing/0000950170-23-061483.md","text":"https://secwatch.observer/filing/0000950170-23-061483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/0000950170-23-061483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/avah-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:33:53.598952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"471df15154167e8eac7775ef8b8ea34c3668af42","claim":"Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended September 30, 2023 results: revenue $478.0 million, net income Net loss was $102.4 million, EPS Net loss per diluted share was $(0.54). Guidance raised.","evidence_excerpt":"by reference in this Item 2.02. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS • Revenue was $478.0 million, a 7.9% increase over the prior year o Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 • Net loss was $102.4 million, inclusive of a $105.1 million non-cash","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/0000950170-23-061483-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine-month periods ended September 30, 2023"},{"label":"Revenue","value":"$478.0 million"},{"label":"Net income","value":"Net loss was $102.4 million"},{"label":"EPS","value":"Net loss per diluted share was $(0.54)"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}